Brief: Innovative Pharmaceutical Biotech Posts FY Profit Attributable HK$103.4 Mln Versus Loss HK$245.7 Mln
June 28 (Reuters) - Innovative Pharmaceutical Biotech
Ltd 0399.HK :
* FY PROFIT ATTRIBUTABLE HK$103.4 MILLION VERSUS LOSS
HK$245.7
MILLION
* FY REVENUE HK$6.6 MILLION VERSUS HK$8.1 MILLION
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU